Literature DB >> 14708705

Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation.

Hans Ludger Tillmann1, Heiner Wedemeyer, Michael Peter Manns.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14708705     DOI： 10.1016/s0168-8278(03)00364-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

1.  [4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

Authors:  Markus Peck-Radosavljevic; Johann Deutsch; Peter Ferenci; Ivo Graziadei; Harald Hofer; Heidemarie Holzmann; Wolf-Dietrich Huber; Herman Laferl; Andreas Maieron; Rudolf Stauber; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2010-05-04       Impact factor: 1.704

Review 2.  Hepatitis B virus reactivation with a rituximab-containing regimen.

Authors:  Yutaka Tsutsumi; Yoshiya Yamamoto; Shinichi Ito; Hiroyuki Ohigashi; Souichi Shiratori; Hirohito Naruse; Takanori Teshima
Journal:  World J Hepatol       Date:  2015-09-28

3.  Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho university hospital.

Authors:  Yolanda Faia Manhaes Tolentino; Homero Soares Fogaca; Cyrla Zaltman; Lia Laura Lewis Ximenes; Henrique Sergio Moraes Coelho
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

4.  Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.

Authors:  M Esteve; C Saro; F González-Huix; F Suarez; M Forné; J M Viver
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 5.  Hepatitis B virus reactivation with rituximab-containing regimen.

Authors:  Yutaka Tsutsumi; Yoshiya Yamamoto; Joji Shimono; Hiroyuki Ohhigashi; Takanori Teshima
Journal:  World J Hepatol       Date:  2013-11-27

Review 6.  Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.

Authors:  Stefano Sansone; Maria Guarino; Fabiana Castiglione; Antonio Rispo; Francesco Auriemma; Ilaria Loperto; Matilde Rea; Nicola Caporaso; Filomena Morisco
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

7.  Occult hepatitis B virus infection as a cause of posttransfusion hepatitis in patients with cancers.

Authors:  Jaswinder Singh Sodhi; Nayeem Wani; Samoon Jeelani; Sajad Geelani; Fehmida Akhtar; Gul Javid; Gh Nabi Yattoo; Altaf Shah; Gh Mohd Gulzar; Mushtaq A Khan; Shaheena Parveen; Riyaz-U Saif; Abid Showkat
Journal:  Indian J Gastroenterol       Date:  2013-03-20

8.  Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients.

Authors:  Alfredo Marzano; Andrea Marengo; Michela di Fonzo; Paola Begini; Antonella Ferrari; Bruno Monarca; Gianfranco Delle Fave; Massimo Marignani
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-12-13       Impact factor: 2.576
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.